Positive start to fiscal 2008 for CardioDynamics as net loss narrows:
This article was originally published in Clinica
Executive Summary
A 22% increase in sales helped impedance cardiology (ICG) firm CardioDynamics narrow its net loss for the first quarter of fiscal 2008. The San Diego, California-based company said the growth in revenues during the quarter (up from $4.7m in Q1 fiscal 2007 to $5.8m) was attributable to a three-fold increase in international sales and a 14% rise in sales of its BioZ non-invasive haemodynamic monitor. International sales improved after CardioDynamics fulfilled large customer orders from the Instituo de Salud del Estado de Mexico and an unnamed multi-hospital purchaser in eastern Europe. Net loss was approximately $1.5m, less 10% compared to the deficit of $1.6m during the same quarter in fiscal 2007.